Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

J. Govan
Journal of the Royal Society of Medicine
Abstract:In patients with cystic fibrosis (CF), chronic colonization with a narrow but evolving spectrum of bacterial pathogens, leading to intermittent episodes of debilitating inflammatory exacerbations and progressive lung damage, are major influences on quality of life and life expectancy. Emerging pathogens also tend to be inherently resistant to available antibiotics depriving patients of effective antibiotic therapy. Thus infection control plays a critical role in the management of CF lung disease.
What problem does this paper attempt to address?